...
首页> 外文期刊>Powder diffraction >Crystal structure of nilotinib, C28H22F3N7O
【24h】

Crystal structure of nilotinib, C28H22F3N7O

机译:尼洛替尼C28H22F3N7O的晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

The crystal structure of nilotinib has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional techniques. Nilotinib crystallizes in space group P1 (#1) with a = 4.518 14(3), b = 10.638 01(5), c = 13.703 77(8)angstrom, alpha = 68.8607(4), beta = 82.1486(5), gamma = 84.1978(5)degrees, V = 607.62(1)angstrom(3), and Z = 1. The most prominent feature of the structure is two strong hydrogen bonds. These form chains with a graph set C1,1(13); the chains run along [111]. Several weak C-H center dot center dot center dot O hydrogen bonds also contribute to the packing. The powder pattern has been submitted to ICDD for inclusion in future releases of the Powder Diffraction File (TM). (C) 2015 International Centre for Diffraction Data.
机译:尼罗替尼的晶体结构已使用同步加速器X射线粉末衍射数据进行了解析和改进,并使用密度泛函技术进行了优化。尼罗替尼在空间群P1(#1)中结晶,a = 4.518 14(3),b = 10.638 01(5),c = 13.703 77(8)埃,α= 68.8607(4),beta = 82.1486(5), γ= 84.1978(5)度,V = 607.62(1)埃(3),Z =1。该结构最突出的特征是两个强氢键。这些形成带有图集C1,1(13)的链;链条沿[111]延伸。几个弱的C-H中心点中心点中心点O氢键也有助于堆积。粉末图案已提交给ICDD,以包含在粉末衍射文件(TM)的未来版本中。 (C)2015年国际衍射数据中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号